EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 254 filers reported holding EXELIXIS INC in Q2 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $261,191 | -41.8% | 11,624 | -38.6% | 0.00% | – |
| Q1 2024 | $448,924 | -2.3% | 18,918 | -1.2% | 0.00% | – |
| Q4 2023 | $459,337 | +10.8% | 19,147 | +0.9% | 0.00% | – |
| Q3 2023 | $414,538 | +103.4% | 18,972 | +77.9% | 0.00% | – |
| Q2 2023 | $203,827 | +0.7% | 10,666 | +2.3% | 0.00% | – |
| Q1 2023 | $202,310 | +16.9% | 10,423 | -5.7% | 0.00% | – |
| Q3 2022 | $173,000 | -43.1% | 11,057 | -24.3% | 0.00% | – |
| Q2 2022 | $304,000 | -22.6% | 14,598 | -15.9% | 0.00% | – |
| Q1 2022 | $393,000 | -96.8% | 17,357 | -97.0% | 0.00% | -100.0% |
| Q2 2019 | $12,356,000 | -10.2% | 578,175 | +0.0% | 0.02% | -11.8% |
| Q1 2019 | $13,760,000 | -9.3% | 578,150 | -25.0% | 0.02% | -19.0% |
| Q4 2018 | $15,167,000 | -13.5% | 771,088 | -22.1% | 0.02% | +5.0% |
| Q3 2018 | $17,544,000 | -16.0% | 990,085 | +2.0% | 0.02% | -13.0% |
| Q2 2018 | $20,894,000 | +32.1% | 970,927 | +36.1% | 0.02% | +27.8% |
| Q1 2018 | $15,811,000 | +841.7% | 713,359 | +1217.2% | 0.02% | +800.0% |
| Q4 2017 | $1,679,000 | -22.6% | 54,158 | -39.5% | 0.00% | -33.3% |
| Q3 2017 | $2,169,000 | +0.1% | 89,537 | +1.8% | 0.00% | 0.0% |
| Q2 2017 | $2,166,000 | -10.2% | 87,932 | -21.0% | 0.00% | 0.0% |
| Q1 2017 | $2,411,000 | +80.6% | 111,269 | +24.3% | 0.00% | +50.0% |
| Q4 2016 | $1,335,000 | +59.1% | 89,550 | +36.5% | 0.00% | +100.0% |
| Q3 2016 | $839,000 | +2367.6% | 65,587 | +555.9% | 0.00% | – |
| Q2 2014 | $34,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
| GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
| Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
| CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
| EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
| CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
| Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
| Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |